Innovation Event

Overview

Place: Switzerland Innovation Park Basel Area AG, Gewerbestrasse 24, 4123 Allschwil

Gabriel Schweizer

Your contact person

Gabriel Schweizer

Senior Project Manager Asia


Tel. +41 61 295 50 13

gabriel.notexisting@nodomain.comschweizer@baselarea.notexisting@nodomain.comswiss
event

12.10.2018

European - Chinese Pharma Partnering

Key topics of the event:
Successful pharma licensing strategies to China, experience and lessons learned

Views on value maximizing partnerships from both European and Chinese perspectives

Challenges and rewards of cross-cultural partnering

Opportunities to meet with some of China’s leading pharma and innovative biotech companies


When: 12.10.2018, 08:45 - 16:00
Where: Switzerland Innovation Park Basel Area, Gewerbestrasse 24, 4123 Allschwil, Switzerland
 
​Who should participate?

Business development executives from European pharma and biotech companies seeking to work with partners from China to expand into the Chinese market.

 
​​Participants from China:
The following companies have confirmed their participation (expect 10 Chinese companies in total)

  • Sihuan Pharmaceutical
  • Humanwell Healthcare
  • Zhejiang Hisun Pharmaceutical
  • Konruns Pharmaceutical
  • Changjiang Runfa Medicine
  • EnnovaBio
  • Junshi Biosciences
  • Space Peptides

 
Registration:
Registration fee of EUR 200. Register here.
 
 

Program 

Part 1 - The European perspective on challenges and opportunities of partnering

8:45 Hans Peter Hasler, Chairman HBM Healthcare Investments: Venturing
into uncharted waters. Lessons learned
9:00 Jean-Marc Sequier, Global Head of Divestments, Out-licensing at Novartis
Pharma: Out-partnering and divestment activities at Novartis
 
9:30 Peter L. Dolan, Senior Director Strategy and Business Development at
Sanofi: Successful pharma licensing strategies
 
10:00 Laurenz Kellenberger, Chief Scientific Officer at Basilea Pharmaceuticals:
SME perspective on licensing/distribution to Chinese companies
 
10:30 Coffee break
 

  

Part 2 - The Chinese perspective on partnering 

11:00 Chris Lu, CEO at Laekna Therapeutics: Chinese deal perspective
11:30 Jianyong Shou, Chief Scientific Officer at EnnovaBio: Value created partnership
in the current Chinese drug discovery and development ecosystem
Innovative Chinese Biotech perspective
 
12:00 Panel discussion: lessons learned, challenges and future trends
Jörg Kazenwadel, Head of R&D Out-licensing at Roche Pharma
Huaizhong Hu, Head of R&D at Konruns Pharmaceutical
 
12:30 Networking lunch

 

Part 3 - Company presentation session 

13:30 Company presentations
16:00 End of event

 
 
 

 

Cookies

BaselArea.swiss uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.

Ok